Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Blood Cancer Detection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4696066
    • |
  • 11 May, 2026
    • |
  • Global
    • |
  • 137 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Blood Cancer Detection market size was valued at US$ 2805 million in 2025 and is forecast to a readjusted size of US$ 4161 million by 2032 with a CAGR of 5.9% during review period.
Diagnosis of hematological tumors is the analysis and diagnosis of tumors using blood
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Blood Cancer Detection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Cancer Detection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Blood Cancer Detection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Blood Cancer Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Blood Cancer Detection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Cancer Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Cancer Detection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, F.Hoffman-LaRoche, QIAGEN, Thermo Fisher Scientific, lllumina, Bio-Rad Laboratories, MolecularMD, ArcherDX, ARUP Laboratories, Asuragen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Blood Cancer Detection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Serve
Detection Kit
Market segment by Application
Clinical Laboratory
Hospital
Academic Research Institution
Other
Major players covered
Abbott Laboratories
F.Hoffman-LaRoche
QIAGEN
Thermo Fisher Scientific
lllumina
Bio-Rad Laboratories
MolecularMD
ArcherDX
ARUP Laboratories
Asuragen
Invivoscribe
AdaptiveBiotechnologies
Amoy Diagnostics
ELITechGroup
VelaDiagnostics
Gentronix
BiolVT
SAGA Diagnostics
Olink
Cancer Diagnostics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood Cancer Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Blood Cancer Detection, with price, sales quantity, revenue, and global market share of Blood Cancer Detection from 2021 to 2026.
Chapter 3, the Blood Cancer Detection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood Cancer Detection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Blood Cancer Detection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Blood Cancer Detection.
Chapter 14 and 15, to describe Blood Cancer Detection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Blood Cancer Detection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Serve
    • 1.3.3 Detection Kit
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Blood Cancer Detection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Clinical Laboratory
    • 1.4.3 Hospital
    • 1.4.4 Academic Research Institution
    • 1.4.5 Other
  • 1.5 Global Blood Cancer Detection Market Size & Forecast
    • 1.5.1 Global Blood Cancer Detection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Blood Cancer Detection Sales Quantity (2021-2032)
    • 1.5.3 Global Blood Cancer Detection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Blood Cancer Detection Product and Services
    • 2.1.4 Abbott Laboratories Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbott Laboratories Recent Developments/Updates
  • 2.2 F.Hoffman-LaRoche
    • 2.2.1 F.Hoffman-LaRoche Details
    • 2.2.2 F.Hoffman-LaRoche Major Business
    • 2.2.3 F.Hoffman-LaRoche Blood Cancer Detection Product and Services
    • 2.2.4 F.Hoffman-LaRoche Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 F.Hoffman-LaRoche Recent Developments/Updates
  • 2.3 QIAGEN
    • 2.3.1 QIAGEN Details
    • 2.3.2 QIAGEN Major Business
    • 2.3.3 QIAGEN Blood Cancer Detection Product and Services
    • 2.3.4 QIAGEN Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 QIAGEN Recent Developments/Updates
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Blood Cancer Detection Product and Services
    • 2.4.4 Thermo Fisher Scientific Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.5 lllumina
    • 2.5.1 lllumina Details
    • 2.5.2 lllumina Major Business
    • 2.5.3 lllumina Blood Cancer Detection Product and Services
    • 2.5.4 lllumina Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 lllumina Recent Developments/Updates
  • 2.6 Bio-Rad Laboratories
    • 2.6.1 Bio-Rad Laboratories Details
    • 2.6.2 Bio-Rad Laboratories Major Business
    • 2.6.3 Bio-Rad Laboratories Blood Cancer Detection Product and Services
    • 2.6.4 Bio-Rad Laboratories Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bio-Rad Laboratories Recent Developments/Updates
  • 2.7 MolecularMD
    • 2.7.1 MolecularMD Details
    • 2.7.2 MolecularMD Major Business
    • 2.7.3 MolecularMD Blood Cancer Detection Product and Services
    • 2.7.4 MolecularMD Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 MolecularMD Recent Developments/Updates
  • 2.8 ArcherDX
    • 2.8.1 ArcherDX Details
    • 2.8.2 ArcherDX Major Business
    • 2.8.3 ArcherDX Blood Cancer Detection Product and Services
    • 2.8.4 ArcherDX Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 ArcherDX Recent Developments/Updates
  • 2.9 ARUP Laboratories
    • 2.9.1 ARUP Laboratories Details
    • 2.9.2 ARUP Laboratories Major Business
    • 2.9.3 ARUP Laboratories Blood Cancer Detection Product and Services
    • 2.9.4 ARUP Laboratories Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 ARUP Laboratories Recent Developments/Updates
  • 2.10 Asuragen
    • 2.10.1 Asuragen Details
    • 2.10.2 Asuragen Major Business
    • 2.10.3 Asuragen Blood Cancer Detection Product and Services
    • 2.10.4 Asuragen Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Asuragen Recent Developments/Updates
  • 2.11 Invivoscribe
    • 2.11.1 Invivoscribe Details
    • 2.11.2 Invivoscribe Major Business
    • 2.11.3 Invivoscribe Blood Cancer Detection Product and Services
    • 2.11.4 Invivoscribe Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Invivoscribe Recent Developments/Updates
  • 2.12 AdaptiveBiotechnologies
    • 2.12.1 AdaptiveBiotechnologies Details
    • 2.12.2 AdaptiveBiotechnologies Major Business
    • 2.12.3 AdaptiveBiotechnologies Blood Cancer Detection Product and Services
    • 2.12.4 AdaptiveBiotechnologies Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 AdaptiveBiotechnologies Recent Developments/Updates
  • 2.13 Amoy Diagnostics
    • 2.13.1 Amoy Diagnostics Details
    • 2.13.2 Amoy Diagnostics Major Business
    • 2.13.3 Amoy Diagnostics Blood Cancer Detection Product and Services
    • 2.13.4 Amoy Diagnostics Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Amoy Diagnostics Recent Developments/Updates
  • 2.14 ELITechGroup
    • 2.14.1 ELITechGroup Details
    • 2.14.2 ELITechGroup Major Business
    • 2.14.3 ELITechGroup Blood Cancer Detection Product and Services
    • 2.14.4 ELITechGroup Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 ELITechGroup Recent Developments/Updates
  • 2.15 VelaDiagnostics
    • 2.15.1 VelaDiagnostics Details
    • 2.15.2 VelaDiagnostics Major Business
    • 2.15.3 VelaDiagnostics Blood Cancer Detection Product and Services
    • 2.15.4 VelaDiagnostics Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 VelaDiagnostics Recent Developments/Updates
  • 2.16 Gentronix
    • 2.16.1 Gentronix Details
    • 2.16.2 Gentronix Major Business
    • 2.16.3 Gentronix Blood Cancer Detection Product and Services
    • 2.16.4 Gentronix Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Gentronix Recent Developments/Updates
  • 2.17 BiolVT
    • 2.17.1 BiolVT Details
    • 2.17.2 BiolVT Major Business
    • 2.17.3 BiolVT Blood Cancer Detection Product and Services
    • 2.17.4 BiolVT Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 BiolVT Recent Developments/Updates
  • 2.18 SAGA Diagnostics
    • 2.18.1 SAGA Diagnostics Details
    • 2.18.2 SAGA Diagnostics Major Business
    • 2.18.3 SAGA Diagnostics Blood Cancer Detection Product and Services
    • 2.18.4 SAGA Diagnostics Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 SAGA Diagnostics Recent Developments/Updates
  • 2.19 Olink
    • 2.19.1 Olink Details
    • 2.19.2 Olink Major Business
    • 2.19.3 Olink Blood Cancer Detection Product and Services
    • 2.19.4 Olink Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Olink Recent Developments/Updates
  • 2.20 Cancer Diagnostics
    • 2.20.1 Cancer Diagnostics Details
    • 2.20.2 Cancer Diagnostics Major Business
    • 2.20.3 Cancer Diagnostics Blood Cancer Detection Product and Services
    • 2.20.4 Cancer Diagnostics Blood Cancer Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Cancer Diagnostics Recent Developments/Updates

3 Competitive Environment: Blood Cancer Detection by Manufacturer

  • 3.1 Global Blood Cancer Detection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Blood Cancer Detection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Blood Cancer Detection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Blood Cancer Detection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Blood Cancer Detection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Blood Cancer Detection Manufacturer Market Share in 2025
  • 3.5 Blood Cancer Detection Market: Overall Company Footprint Analysis
    • 3.5.1 Blood Cancer Detection Market: Region Footprint
    • 3.5.2 Blood Cancer Detection Market: Company Product Type Footprint
    • 3.5.3 Blood Cancer Detection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Blood Cancer Detection Market Size by Region
    • 4.1.1 Global Blood Cancer Detection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Blood Cancer Detection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Blood Cancer Detection Average Price by Region (2021-2032)
  • 4.2 North America Blood Cancer Detection Consumption Value (2021-2032)
  • 4.3 Europe Blood Cancer Detection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Blood Cancer Detection Consumption Value (2021-2032)
  • 4.5 South America Blood Cancer Detection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Blood Cancer Detection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Blood Cancer Detection Sales Quantity by Type (2021-2032)
  • 5.2 Global Blood Cancer Detection Consumption Value by Type (2021-2032)
  • 5.3 Global Blood Cancer Detection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Blood Cancer Detection Sales Quantity by Application (2021-2032)
  • 6.2 Global Blood Cancer Detection Consumption Value by Application (2021-2032)
  • 6.3 Global Blood Cancer Detection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Blood Cancer Detection Sales Quantity by Type (2021-2032)
  • 7.2 North America Blood Cancer Detection Sales Quantity by Application (2021-2032)
  • 7.3 North America Blood Cancer Detection Market Size by Country
    • 7.3.1 North America Blood Cancer Detection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Blood Cancer Detection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Blood Cancer Detection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Blood Cancer Detection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Blood Cancer Detection Market Size by Country
    • 8.3.1 Europe Blood Cancer Detection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Blood Cancer Detection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Blood Cancer Detection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Blood Cancer Detection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Blood Cancer Detection Market Size by Region
    • 9.3.1 Asia-Pacific Blood Cancer Detection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Blood Cancer Detection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Blood Cancer Detection Sales Quantity by Type (2021-2032)
  • 10.2 South America Blood Cancer Detection Sales Quantity by Application (2021-2032)
  • 10.3 South America Blood Cancer Detection Market Size by Country
    • 10.3.1 South America Blood Cancer Detection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Blood Cancer Detection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Blood Cancer Detection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Blood Cancer Detection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Blood Cancer Detection Market Size by Country
    • 11.3.1 Middle East & Africa Blood Cancer Detection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Blood Cancer Detection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Blood Cancer Detection Market Drivers
  • 12.2 Blood Cancer Detection Market Restraints
  • 12.3 Blood Cancer Detection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Blood Cancer Detection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Blood Cancer Detection
  • 13.3 Blood Cancer Detection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Blood Cancer Detection Typical Distributors
  • 14.3 Blood Cancer Detection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Blood Cancer Detection. Industry analysis & Market Report on Blood Cancer Detection is a syndicated market report, published as Global Blood Cancer Detection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Blood Cancer Detection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo